Impact of Anti-Glaucoma Medications (Polytherapy Versus Monotherapy) On Ocular Surface Changes: A Cross-Sectional Study
International Journal of Drug Delivery Technology · 08.05.2026 · 16 (25s)
DOI: 10.25258/ijddt.16.25s.76 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.05.2026. Verfasst von Acharya Y und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
Anti-glaucoma medications are a well-established cause of ocular surface disease (OSD); however, whether medication burden monotherapy versus polytherapy differentially affects the ocular surface remains underexplored in the Indian population. This study aimed to compare ocular surface parameters between patients on single-drug and multidrug regimens and to examine the relationship between intraocular pressure (IOP) levels and ocular surface status.
Methods
A cross-sectional, observational study was conducted at a tertiary eye care centre in Gurugram, Haryana (January–December 2025). Seventy-two adults with bilateral primary open-angle glaucoma (POAG) on stable topical therapy for ≥6 months were enrolled: 36 on monotherapy and 36 on polytherapy. Ocular surface evaluation included the Ocular Surface Disease Index (OSDI) questionnaire, Non-Invasive tear break-up time (NIBUT), Schirmer’s Test I (without anaesthesia), Oxford corneal staining grade, and Goldmann applanation tonometry. Data were analysed with Jamovi v2.3 using Student’s independent t-test, Mann–Whitney U test, chi-square test, and Spearman’s rank correlation; significance was set at p < 0.05.
Results
Groups were well-matched for age (p = 0.42) and sex (p = 0.61). Polytherapy patients demonstrated significantly worse performance across all ocular surface metrics: OSDI score (32.6 ± 8.4 vs. 21.3 ± 6.1, p < 0.001), NIBUT (6.8 ± 1.9 s vs. 10.9 ± 2.4 s, p < 0.001), Schirmer’s test (8.2 ± 2.6 mm vs. 12.4 ± 3.1 mm, p < 0.001), and Oxford staining grade (median 3 [IQR 2–4] vs. 1 [IQR 1–2], p < 0.001). IOP showed moderate positive correlations with OSDI (r = +0.52, p < 0.001) and Oxford grade (r = +0.52, p < 0.001), and moderate-to-weak negative correlations with NIBUT (r = −0.52, p < 0.001) and Schirmer’s test (rₛ = −0.41, p = 0.002).
Conclusion
Polytherapy for POAG is associated with substantially greater ocular surface compromise than monotherapy. IOP levels correlate with ocular surface parameters, suggesting a reciprocal relationship between pressure control and surface health. Strategies to reduce medication burden by including fixed-dose combinations, preservativefree formulations, and laser trabeculoplasty merit consideration in patients with concurrent OSD.
Zitieren
APA
Y, A., R, S., & K, M. (2026). Impact of Anti-Glaucoma Medications (Polytherapy Versus Monotherapy) On Ocular Surface Changes: A Cross-Sectional Study. International Journal of Drug Delivery Technology, 16(25s). https://doi.org/10.25258/ijddt.16.25s.76
Vancouver
Y A, R S, K M. Impact of Anti-Glaucoma Medications (Polytherapy Versus Monotherapy) On Ocular Surface Changes: A Cross-Sectional Study. International Journal of Drug Delivery Technology. 2026;16(25s). doi:10.25258/ijddt.16.25s.76
BibTeX
@article{Y2026,
author = {Y, Acharya and R, Sengupta and K, Marwah},
title = {Impact of Anti-Glaucoma Medications (Polytherapy Versus Monotherapy) On Ocular Surface Changes: A Cross-Sectional Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {25s},
doi = {10.25258/ijddt.16.25s.76}
}
EUVIMED